Annual Operating Expenses:
$177.38M+$127.03M(+252.34%)Summary
- As of today, CDTX annual total operating expenses is $177.38 million, with the most recent change of +$127.03 million (+252.34%) on December 31, 2024.
- During the last 3 years, CDTX annual operating expenses has risen by +$85.55 million (+93.16%).
- CDTX annual operating expenses is now at all-time high.
Performance
CDTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$43.60M+$12.31M(+39.33%)Summary
- As of today, CDTX quarterly total operating expenses is $43.60 million, with the most recent change of +$12.31 million (+39.33%) on September 30, 2025.
- Over the past year, CDTX quarterly operating expenses has increased by +$26.27 million (+151.54%).
- CDTX quarterly operating expenses is now -19.44% below its all-time high of $54.12 million, reached on December 31, 2024.
Performance
CDTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CDTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +252.3% | +151.5% |
| 3Y3 Years | +93.2% | +69.1% |
| 5Y5 Years | +183.2% | +148.7% |
CDTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +252.3% | -19.4% | +360.9% |
| 5Y | 5-Year | at high | +252.3% | -19.4% | +504.7% |
| All-Time | All-Time | at high | >+9999.0% | -19.4% | +504.7% |
CDTX Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $43.60M(+39.3%) |
| Jun 2025 | - | $31.29M(+1.8%) |
| Mar 2025 | - | $30.73M(-43.2%) |
| Dec 2024 | $177.38M(+252.3%) | $54.12M(+212.3%) |
| Sep 2024 | - | $17.33M(+52.8%) |
| Jun 2024 | - | $11.35M(+19.9%) |
| Mar 2024 | - | $9.46M(-17.2%) |
| Dec 2023 | $50.34M(-48.6%) | $11.42M(-16.4%) |
| Sep 2023 | - | $13.66M(+15.7%) |
| Jun 2023 | - | $11.81M(-49.3%) |
| Mar 2023 | - | $23.29M(-1.6%) |
| Dec 2022 | $97.95M(+6.7%) | $23.68M(-8.2%) |
| Sep 2022 | - | $25.78M(+33.7%) |
| Jun 2022 | - | $19.29M(-23.8%) |
| Mar 2022 | - | $25.33M(+5.7%) |
| Dec 2021 | $91.83M(+9.4%) | $23.96M(+32.8%) |
| Sep 2021 | - | $18.04M(+267.4%) |
| Jun 2021 | - | -$10.77M(-159.1%) |
| Mar 2021 | - | $18.22M(-15.4%) |
| Dec 2020 | $83.92M(+34.0%) | $21.55M(+22.9%) |
| Sep 2020 | - | $17.53M(-3.7%) |
| Jun 2020 | - | $18.21M(+25.1%) |
| Mar 2020 | - | $14.56M(+3.4%) |
| Dec 2019 | $62.64M | $14.08M(+565.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -$3.03M(-121.3%) |
| Jun 2019 | - | $14.18M(-13.1%) |
| Mar 2019 | - | $16.32M(-1.0%) |
| Dec 2018 | $63.28M(+13.6%) | $16.49M(+13.0%) |
| Sep 2018 | - | $14.59M(-9.5%) |
| Jun 2018 | - | $16.13M(-3.3%) |
| Mar 2018 | - | $16.67M(+25.2%) |
| Dec 2017 | $55.72M(+15.0%) | $13.32M(+10.0%) |
| Sep 2017 | - | $12.11M(-26.3%) |
| Jun 2017 | - | $16.43M(+24.5%) |
| Mar 2017 | - | $13.20M(-6.8%) |
| Dec 2016 | $48.44M(+49.9%) | $14.17M(+16.5%) |
| Sep 2016 | - | $12.16M(+4.2%) |
| Jun 2016 | - | $11.67M(+20.3%) |
| Mar 2016 | - | $9.71M(-0.5%) |
| Dec 2015 | $32.31M(+222.6%) | $9.76M(+7.1%) |
| Sep 2015 | - | $9.11M(+43.5%) |
| Jun 2015 | - | $6.35M(-4.4%) |
| Mar 2015 | - | $6.64M(+45.6%) |
| Dec 2014 | $10.02M(+825.7%) | $4.56M(+37.3%) |
| Sep 2014 | - | $3.32M(+123.1%) |
| Jun 2014 | - | $1.49M(+166.2%) |
| Mar 2014 | - | $559.00K |
| Dec 2013 | $1.08M | - |
FAQ
- What is Cidara Therapeutics, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Cidara Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of CDTX is $177.38M
What is the all-time high annual operating expenses for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual total operating expenses is $177.38M
What is Cidara Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, CDTX annual total operating expenses has changed by +$127.03M (+252.34%)
What is Cidara Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of CDTX is $43.60M
What is the all-time high quarterly operating expenses for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly total operating expenses is $54.12M
What is Cidara Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, CDTX quarterly total operating expenses has changed by +$26.27M (+151.54%)